British Amer Financials
| BTI Stock | CAD 1.26 1.25 25,100% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.29 | 0.3 |
|
|
British | Select Account or Indicator |
Understanding current and past British Amer Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of British Amer's financial statements are interrelated, with each one affecting the others. For example, an increase in British Amer's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in British Amer's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of biOasis Technologies. Check British Amer's Beneish M Score to see the likelihood of British Amer's management manipulating its earnings.
British Amer Stock Summary
British Amer competes with Questor Technology, Richelieu Hardware, ISign Media, Cogeco Communications, and Advent Wireless. Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company was founded in 2007 and is based in New Haven, Connecticut. British Amer operates under Biotechnology classification in Exotistan and is traded on Commodity Exchange.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | Canada Stock View All |
| Exchange | TSX Venture Exchange |
| ISIN | CA09064N1033 |
| Business Address | 157 Church Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bioasis.us |
| Phone | 203 533 7082 |
| Currency | CAD - Canadian Dollar |
You should never invest in British Amer without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of British Stock, because this is throwing your money away. Analyzing the key information contained in British Amer's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
British Amer Key Financial Ratios
There are many critical financial ratios that British Amer's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that biOasis Technologies reports annually and quarterly.| Operating Margin | (4.69) % | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 269.38 K | ||||
| Gross Profit | (1.19 M) | ||||
| EBITDA | (2.98 M) |
British Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining British Amer's current stock value. Our valuation model uses many indicators to compare British Amer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across British Amer competition to find correlations between indicators driving British Amer's intrinsic value. More Info.biOasis Technologies is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . At this time, British Amer's Operating Profit Margin is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the British Amer's earnings, one of the primary drivers of an investment's value.biOasis Technologies Systematic Risk
British Amer's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. British Amer volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on biOasis Technologies correlated with the market. If Beta is less than 0 British Amer generally moves in the opposite direction as compared to the market. If British Amer Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one biOasis Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of British Amer is generally in the same direction as the market. If Beta > 1 British Amer moves generally in the same direction as, but more than the movement of the benchmark.
biOasis Technologies Total Assets Over Time
Today, most investors in British Amer Stock are looking for potential investment opportunities by analyzing not only static indicators but also various British Amer's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of British Amer growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
British Amer November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of British Amer help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of biOasis Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of biOasis Technologies based on widely used predictive technical indicators. In general, we focus on analyzing British Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build British Amer's daily price indicators and compare them against related drivers.
| Downside Deviation | 49.81 | |||
| Information Ratio | 0.2829 | |||
| Maximum Drawdown | 25599.6 | |||
| Value At Risk | (99.60) | |||
| Potential Upside | 24900.0 |
Additional Tools for British Stock Analysis
When running British Amer's price analysis, check to measure British Amer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy British Amer is operating at the current time. Most of British Amer's value examination focuses on studying past and present price action to predict the probability of British Amer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move British Amer's price. Additionally, you may evaluate how the addition of British Amer to your portfolios can decrease your overall portfolio volatility.